Markets.com Logo

SLP

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    13.8749$
  • Previous Close
    13.8592$
  • 52 Week Change
    25.28$
  • Day Range
    0.02$
  • 52 Week High/Low
    12.39$ - 37.67$
  • Dividend Per Share
    0.0073
  • Market cap
    277 M$
  • EPS
    -3.3469
  • Beta
    0.761
  • Volume
    --

About

SLP.US represents Simulations Plus, Inc., a leading provider of simulation and modeling software and consulting services for pharmaceutical, biotechnology, chemicals, and consumer goods companies. The company's products are used to predict the behavior of drugs and chemicals in the body, helping clients to optimize product development, reduce time to market, and improve the safety and efficacy of their products. Simulations Plus is publicly traded on the NASDAQ stock exchange under the ticker symbol SLP. They offer a suite of software tools for various applications, including drug discovery, preclinical and clinical development, and regulatory submissions.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

SLP.US, representing Simulations Plus Inc., is influenced by several factors: Financial Performance: Revenue growth, profitability, and earnings reports significantly impact investor confidence.

Industry Trends: Pharmaceutical and biotechnology industry growth, R&D spending trends affect demand for simulation software.

Competitive Landscape: Market share, competition from other simulation software providers, and technological advancements matter.

Regulatory Environment: Changes in drug development regulations and approvals influence the need for simulation tools.

Acquisitions and Partnerships: Mergers, acquisitions, and strategic alliances can alter the company's growth prospects.

Overall Market Conditions: Broader economic factors, investor sentiment, and market volatility affect stock prices generally.

Company-Specific News: Product releases, significant customer wins, and key management changes can influence investor perceptions.

Technological Innovation: Development and adoption of new simulation technologies drive future growth potential.

Analyst Ratings: Investment analysts' assessments and target price recommendations influence investor behavior.

Global Events: Major global events, such as pandemics or economic crises, can impact the pharmaceutical industry.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--